Compare Humana Inc (HUM) vs Lululemon Athletica Inc (LULU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Lululemon Athletica Inc — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Lululemon Athletica Inc trades at $125.44 (market cap $14.51B). The key difference: Humana Inc is far larger — about 3.2× Lululemon Athletica Inc's market cap, and Humana Inc pays a 0.92% dividend while Lululemon Athletica Inc pays none. Which is the better fit depends on your goals.
| HUM | LULU | |
|---|---|---|
Market Cap | $46.31B | $14.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $215.88 |
52-Week Low | $163.67 | $105.43 |
Enterprise Value | $53.67B | $15.13B |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Lululemon (LULU) trades at $128.58, up 3.09% today, showing strong momentum near the consensus price target of $129.29. The company demonstrates robust fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.69 beating expectations of $1.67. Revenue growth has accelerated from $6.3B in 2022 to $10.6B in 2025, while maintaining healthy profit margins above 13%. Technical indicators show bullish momentum with the current price above key support levels, though RSI readings suggest potential overbought conditions.
Lululemon presents a compelling investment case with strong international growth, particularly in China, and operational improvements supporting the bullish thesis. However, risks include competitive pressures in the premium activewear space and potential margin compression as revenue growth moderates. The stock appears reasonably valued with a P/E of 10.41 and P/S of 1.35, offering upside potential if international expansion continues to outperform.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Lululemon Athletica Inc
Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Read more on LULU →
